New monthly bladder therapy could ease overactive bladder symptoms
NCT ID NCT07391878
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment called TRG-200 KIT for people with overactive bladder (OAB) who haven't found relief from standard therapies. The treatment is given once a month through a catheter into the bladder and slowly releases medication to reduce urgent bathroom trips and accidents. The goal is to see if it is safe and effective, with fewer side effects than daily pills.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER (OAB) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shaare Zedek Medical Center
Jerusalem, 9103102, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nerve zap ease bladder urgency after stroke?
- Could common bladder medications change how men ejaculate? a study investigates
- Muscle training with biofeedback may curb bladder leaks — trial puts it to the test
- Personalizing bladder treatment: could your other pills determine which drug works best?
- Could a gentle leg tingle replace pain pills during bladder botox?
- Could probiotics calm your bladder and your anxiety?